Metformin and Gastrointestinal Side Effects

Introduction to Metformin's Gastrointestinal Effects

Metformin, a first-line agent for type 2 diabetes management, is associated with several gastrointestinal side effects, including abdominal bloating, flatulence, diarrhea, nausea, vomiting, and reduction in appetite, according to the American Diabetes Association 1, 3, 4
These side effects can be problematic for some patients, particularly older adults, as noted by the American Geriatrics Society 1, 4

To minimize gastrointestinal side effects, the American Diabetes Association recommends slowly increasing the daily dose of metformin 1
The American Diabetes Association also suggests considering dose reduction or elimination if persistent gastrointestinal side effects occur 1, 4

In cases of intestinal occlusion/obstruction from other causes, metformin may accumulate in the body even without renal failure, and the European Association for the Study of Diabetes recommends temporary discontinuation of metformin during acute illness that may compromise renal or liver function, including conditions like bowel obstruction 1, 4, 5
The American College of Gastroenterology notes that metformin should be temporarily discontinued during hospitalizations for acute illness, including bowel obstruction from other causes, to avoid potential complications 1, 4, 5